On September 1, 2022 Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) reported that it is scheduled to participate in the following upcoming events (Press release, Arrowhead Pharmaceuticals, SEP 1, 2022, View Source [SID1234618903]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

European Respiratory Society (ERS) International Congress 2022 – September 4-6, 2022

Title: Silencing MMP7 expression with a lung-targeted RNAi molecule limits fibrosis and preserves pulmonary function in bleomycin-injured rats
Presenter: Erik Bush, Ph.D., Group Vice President, Biology, Arrowhead Pharmaceuticals

2022 Wells Fargo Healthcare Conference – September 7-9, 2022

Type: Investor meetings
Presenter: Vincent Anzalone, CFA, Vice President Finance and Investor Relations, Arrowhead Pharmaceuticals

H.C. Wainwright 24th Annual Global Investment Conference – September 12-14, 2022

Type: Fireside chat presentation
Presenter: Christopher Anzalone, Ph.D., President and CEO, Arrowhead Pharmaceuticals

Baird 2022 Global Healthcare Conference – September 13-14, 2022

Type: Fireside chat presentation
Presenter: Christopher Anzalone, Ph.D., President and CEO, Arrowhead Pharmaceuticals

Morgan Stanley 20th Annual Global Healthcare Conference – September 12-14, 2022

Type: Fireside chat presentation
Presenter: Christopher Anzalone, Ph.D., President and CEO, Arrowhead Pharmaceuticals

A copy of the presentation materials and webcast links may be accessed on the Events and Presentations page under the Investors section of the Arrowhead website.